EuropaBio Healthcare Biotechnology


		In medicine, biotechnology offers the possibility to understand how our DNA interacts with diseases. Biotechnology creates treatments that have the potential to address medical conditions, not just symptoms. With biotechnology, we also gain the tools to regenerate damaged cells and tissue; these are already proving an effective way to treat heart disease and some forms of cancer ... Healthcare Biotechnology Facts and Figures Discover how healthcare biotech is making a difference

Healthcare Council News

Position Papers

14/05/2008

EuropaBio input to the Public Consultation in Preparation of a Legal Proposal to Combat Counterfeit Medicines for Human Use

08/04/2008

Submission to the EU Public Consultation on a Legal Proposal on Information to Patients

Press Releases

29/02/2008

EuropaBio supports patient action for Rare Disease Day
EuropaBio Briefing - Rare Diseases: Europe's Challenges

14/02/2008

Biotech industry supports common security market for Bio-Preparedness

Ask the Healthcare Council

Q. What is the potential impact of genetic research on new medicines in Europe today? NEW

Answer

All Ask the Healthcare Council

Events & News

May 2008 - Rare Diseases: Europe's Challenges - EuropaBio Article in Scrip
April 2008 - Testing New Technology - Article in the Public Service Review: European Union
April 2008 - EuropaBio Sessions at BIO 2008

Inside the Healthcare Council

	Valuing Healthcare Innovation
	Spreading awareness that that the value of biotech healthcare treatments goes beyond curing the patients.
	EuropaBio's campaign

	Orphan Medicines
	Biotechnology provides powerful tools to develop diagnostics and treatments for the 20-30 million Europeans affected by rare diseases.
	EuropaBio's campaign

	Information to Patients
	Campaigning for more and better information to patients on biotech treatments
	EuropaBio's campaign

Activities